Low-Dose Hyperradiosensitivity: Is There a Place for Future Investigation in Clinical Settings?

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 535-539

  Valentini, Vincenzo ^a   Massaccesi, Mariangela ^a   Balducci, Mario ^a   Mantini, Giovanna ^a   Micciché, Francesco ^a   Mattiucci, Gian Carlo ^a   Dinapoli, Nicola ^a   Meduri, Bruno ^a   D'Agostino, Giuseppe Roberto ^a   Salvi, Giovanna ^a   Nardone, Luigia ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Head and neck cancer; Low dose hyperradiosensivity; Lung cancer; Radiochemotherapy; Ultrafractionated radiotherapy

Indexed keywords

BREAST CANCER; CLINICAL EFFICACY; CLINICAL SETTINGS; ESOPHAGEAL CARCINOMA; FRACTIONATED RADIOTHERAPY; HEAD-AND-NECK CANCER; HEAD-AND-NECK TUMOR; HEMATOLOGIC TOXICITY; HYPERRADIOSENSITIVITY; IN-VITRO; LOW DOSE; LUNG CANCER; PATIENT POPULATION; PER UNIT; PHASE II; PRECLINICAL STUDIES; RADIATION DOSE; RADIATION THERAPY ONCOLOGY GROUPS; RADIOCHEMOTHERAPY; RESPONSE RATE; TOTAL DOSE; TUMOR CELL LINES;

BIOLOGICAL ORGANS; CELL CULTURE; CHEMOTHERAPY; ONCOLOGY; SURVEYS; TOXICITY; TUMORS;

RADIOTHERAPY;

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; PEMETREXED;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CLINICAL ARTICLE; EPITHELIUM TUMOR; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HEAD AND NECK TUMOR; HUMAN; HYPERRADIOSENSITIVITY; INTRADUCTAL CARCINOMA; LARYNX CANCER; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; METASTASIS; OCCULT CANCER; PALLIATIVE THERAPY; PHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSENSITIVITY; SALIVARY GLAND CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GLUTAMATES; GUANINE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PALLIATIVE CARE; PROSPECTIVE STUDIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; YOUNG ADULT;

EID: 73649118499     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.075     Document Type: Article

References (34)

1. Durand R.E. Use of a cell sorter for assays of cell clonogenicity. Cancer Res 46 (1986) 2775-2778
2. Lambin P., Coco Martin J., Legal J.D., et al. Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines. Radiat Res 138 (1994) S40-S43
3. Lambin P., Fertil B., Malaise E.P., et al. Multiphasic survival curves for cells of human tumor cell lines: Induced repair or hypersensitive subpopulation?. Radiat Res 138 (1994) S32-S36
4. Lambin P., Malaise E.P., and Joiner M.C. The effect of very low radiation doses on the human bladder carcinoma cell line RT112. Radiother Oncol 32 (1994) 63-72
5. Lambin P., Marples B., Fertil B., et al. Hypersensitivity of a human tumour cell line to very low radiation doses. Int J Radiat Biol 63 (1993) 639-650
6. Short S., Mayes C., Woodcock M., et al. Low dose hypersensitivity in the T98G human glioblastoma cell line. Int J Radiat Biol 75 (1999) 847-855
7. Short S.C., Mitchell S.A., Boulton P., et al. The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol 75 (1999) 1341-1348
8. Wouters B.G., Sy A.M., and Skarsgard L.D. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat Res 146 (1996) 399-413
9. Short S.C., Woodcock M., Marples B., et al. The effects of cell cycle phase on low dose hyper-radiosensitivity. Int J Radiat Biol 79 (2003) 99-105
10. Marples B., Wouters B.G., and Joiner M.C. An association between the radiation-induced arrest of G2 phase cells and low-dose hyper-radiosensitivity: A plausible underlying mechanism?. Radiat Res 160 (2003) 38-45
11. Xu B., Kim S.T., Lim D.S., et al. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22 (2002) 1049-1059
12. Krempler A., Deckbar D., Jeggo P.A., et al. An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cells. Cell Cycle 6 (2007) 1682-1686
13. Enns L., Bogen K.T., Wizniak J., et al. Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis. Mol Cancer Res 2 (2004) 557-566
14. Shepherd F.A., Dancey J., Ramlau R., et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18 (2000) 2095-2103
15. Fossella F.V., DeVore R., Kerr R.N., et al. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol 18 (2000) 2354-2362
16. Hanna N., Shepherd F.A., Fossella F.V., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22 (2004) 1589-1597
17. Forastiere A.A., Metch B., Schuller D.E., et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10 (1992) 1245-1251
18. Forastiere A.A., Leong T., Rowinsky E., et al. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. J Clin Oncol 19 (2001) 1088-1095
19. Gibson M.K., Li Y., Murphy B., et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 3562-3567
20. Soulieres D., Senzer N.N., Vokes E.E., et al. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 22 (2004) 77-85
21. Haraf D.J., Weichselbaum R.R., and Vokes E.E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7 (1996) 913-918
22. Spencer S.A., Harris J., Wheeler R.H., et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51 (2001) 1299-1304
23. Horwitz E.M., Harris J., Langer C.J., et al. Concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN): Update of RTOG 9911. J Clin Oncol 23 (2005) 519s
24. Dey S., Spring P.M., Arnold S., et al. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin Cancer Res 9 (2003) 1557-1565
25. Gupta S., Arnold A.M., Spring P., et al. Low-dose fractionated radiation potentiates the effect of cisplatin independent of the hyper-radiation sensitivity phenomenon in human lung cancer cell lines. [Abstract]. Proc Am Assoc Cancer Res 45 (2004) 1369a
26. Chendil D., Oakes R., Alcock R.A., et al. Low dosefractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer 89 (2000) 1893-1900
27. Spring P.M., Arnold S.M., Shajahan S., et al. Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell Cycle 3 (2004) 479-485
28. Arnold S.M., Regine W.F., Ahmed M.M., et al. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: Results of a new treatment paradigm. Int J Radiat Oncol Biol Phys 58 (2004) 1411-1417
29. Regine W.F., Hanna N., Garofalo M.C., et al. Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: A phase I study exploring a new treatment paradigm. Int J Radiat Oncol Biol Phys 68 (2007) 172-177
30. Short SC, Kelly J, Mayes CR, et al. Low dose hypersensitivity after fractionated low-dose irradiation in vitro. 2001;77:655-664.
31. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. 2000;92:205-216.
32. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Biol 30 (1995) 1341-1346
33. Harney J., Short S.C., Shah N., et al. Low dose hyper-radiosensitivity in metastatic tumors. Int J Radiat Oncol Biol Phys 59 4 (2004) 1190-1195
34. Rödel F., Keilholz L., Herrmann M., et al. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol 83 (2007) 357-366